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Summary.-Seven days on a protein-free diet increases the susceptibility of rats to
the action of DMN as a renal carcinogen. The dose response for the induction of
kidney tumours by a single dose of dimethylnitrosamine (DMN) in these rats is
reported. The first tumour was not found until 28 weeks after the dose. At 100 weeks
the incidence ranged from 22.50/o at the lowest dose (20 mg/kg) to97°h at the highest
dose (60 mg/kg). The incidence in probits at any time between 50 and 100 weeks was
linearly related to the log dose. Epithelial and mesenchymal tumours were produced
in an approximate ratio of 2:1. The protein-free diet alters the rate of metabolism
of DMN in the rat, and increases the alkylation of nucleic acids by this carcinogen in
the kidney. Further treatment of the rat with benzo(a)pyrene can reverse, to some
extent, the change in metabolism, but does not reverse the change in alkylation. It is
shown that the change in kidney-tumour incidence produced by the change in diet,
and by the treatment with benzo(a)pyrene, corresponds to the changes these
treatments produce in the alkylation of kidney DNA by the carcinogen.
THE DISCOVERY that only a single dose
of dimethylnitrosamine (DMN) is needed
to induce kidney tumours in the rat
(Magee & Barnes, 1962) was soon followed
by the report that some other N-nitroso
compounds are equally effective (Druckrey
et al., 1964). The ability to produce cancer
with a single dose of carcinogen opened
the way to a number of previously impos-
sible experiments. However, each of these
carcinogenic nitroso compounds had some
disadvantage which reduced its usefulness
as an experimental tool. Some produced
tumours in many organs so that it was
difficult to study one single type oftumour,
and others, which were specific for just one
organ, required a very large dose to induce
even a low incidence of tumours. For
example a median lethal dose of DMN
produced only a 20%0 incidence of kidney
tumours. This low incidence of tumours,
and the many severe changes in the
metabolism of the animal produced by
the near lethal dose, limited the usefulness
ofthis means ofinducing cancer. However,
kidney tumours can be induced in every
rat if the animals are given a protein-free
diet for 7 days before, and 5 days after, the
single dose of DMN (Swann & McLean,
1968; Hard & Butler, 1970; McLean &
Magee, 1970). The diet influences the
effectiveness of the nitrosamine as a renal
carcinogen in 2 ways: it allows the rat to
tolerate a much larger dose (the median
lethal dose is almost doubled) (McLean &
Verschuuren, 1969); and it alters the
pharmacokinetics of the nitrosamine so
that the proportion of any dose activated
to the proximal carcinogen in the kidney
is greatly increased (Swann & McLean,
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1971). These 2 effects complement each
other so that a dose of DMN well below
the LD50 will induce kidney tumours in
every one of the rats (Swann & McLean,
1968; Hard & Butler, 1970; McLean &
Magee, 1970).
The histogenesis and histological de-
velopment of these kidney tumours has
been studied (Hard & Butler, 1970, 1971)
and an attempt has been made to identify
the biochemical events crucial to their
development, by studying the effect on
them of inhibitors of protein and nucleic
acid synthesis (Stewart & Magee, 1973).
Because the results of this study could not
be compared with a dose-response curve
it was unsatisfactory. It could not show
wbether a large or a small change in dose
of carcinogen was needed to produce the
same change in incidence as produced by
the drug treatment. Furthermore, a dose-
response curve would have indicated the
optimum number of animals, and the
most appropriate dose of carcinogen.
In this paper the dose-response for the
induction of kidney tumours by DMN in
these protein-deprived rats is described,
and it is shown that the effect of the
change of diet, and of pretreatment with
benzo(a)pyrene, on the incidence ofkidney
tumours produced by DMN corresponds
to the effect of these treatments on the
alkylation of kidney DNA by the nitro-
samine.
MATERIALS AND METHODS
Animals.- Wistar-derived male rats of
CFN stock (5-6 wNeeks old; 130-140 g) were
bought from Carworth Farms, New City,
N.Y., U.S.A. After 5-7 days' acclimatization,
during which they were fed Purina Chow
(Ralston Purina Corp., St Louis, Mo., U.S.A.),
they were changed to a semi-synthetic diet
containing no protein (McLean & McLean,
1966). Those rats to be treated were weighed
and given an i.p. injection of a solution of
DMN in 015M NaCl (0.5 ml/100 g body wt)
on the morning of the 7th day on the diet.
(Controls were injected with a similar
volume of 0-15M NaCl at the same time.)
After a further 5 days on this diet (i.e. a total
of 12 days) the rats were returned to the
normal diet of Purina Chow. While they were
receiving the protein-deficient diet the rats
were kept in cages with gridded bottoms so
that they were unable to eat faeces or bed-
ding.
Outbred Osborne Mendel rats and inbred
Buffalo rats were supplied by the Laboratory
Aids Branch, National Institutes of Health,
Bethesda, Md 20014, U.S.A.
Determination of the effect of a protein-free
diet on the LD50 of DMN.-The LD5Os were
determined (Weil, 1952) in rats on a normal
diet (Purina Chow) or on protein-free diet.
Twenty-four CFN male rats, 24 Osborne
Mendel male rats, and 24 male Buffalo rats
(in all cases 140-170 g) were acclimatized,
kept on a protein-free diet, and treated with
DMN as detailed above. The LD50 in these
rats was compared with that in a similar
number of rats fed only Purina Chow.
The influence of the protein-deficient diet
or pretreatment with benzo(a)pyrene on the
metabolismof DMN by liver and kidney slices
in vitro, and on the methylation of liver and
kidney DNA in vivo by a single dose of
[14C]DMN.-Previously described methods
(Swann & McLean, 1971) were used to
assess the influence of diet and pretreat-
ment with benzo(a)pyrene on the extent of
methylation of liver and kidney DNA pro-
duced in vivo by a dose of DMN, and upon
the ability of liver and kidney slices to
metabolize DMN in vitro. In both studies
CFN rats were fed either a normal diet, or a
protein-free diet for 7 days. After 4 days,
half the rats on each diet were given a single
i.p. dose of benzo(a)pyrene (20 mg/kg body
wt as an 8mg/ml solution in maize oil). On
the 7th day 5 animals from each group were
given a single i.p. dose of [14C] DMN (40 mg/
kg body wt). The animals on the normal diet
were killed 8 h, and those on the protein-free
diet 15 h, after the dose, and the amount of
N-7-methylguanine in the DNA ofthe pooled
kidneys measured. The interval between dose
and death was longer (15 h) in the animals on
the protein-free diet because these animals
metabolize DMN more slowly. The remaining
animals were also killed and the ability of
slices oftheir livers and kidneys to metabolize
DMN in vitro was measured.
Determination of the incidence of kidney
tumours produced by various amounts of
DMN, and the effect on that incidence of pre-
treatment with benzo(a)pyrene. The CFN rats
were acclimatized, changed to a protein-free
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diet and treated with DMN (20, 30, 40, 50
or 60 mg/kg body wt) as detailed above. The
number of rats in each group is given in
Table II. There was one untreated control
group ofrats on a normal diet (Purina Chow),
and another on the protein-deficient diet.
Both groups were injected with O15M NaCl
(0-5 ml/100 g body wt).
The effect of benzo(a)pyrene on DMN-
induced kidney-tumour incidence in the
protein-deprived rat was studied by giving
one dose (20 mg/kg body wt i.p. as 8 mg/ml
solution in maize oil) 3 days before DMN
(40 mg/kg body wt). One control group was
given only benzo(a)pyrene, and one was kept
on a normal diet (Purina) and given a single
dose ofDMN (40 mg/kg body wt).
Animals were killed if moribund or found
to have a palpable tumour. All animals wvere
necropsied. The liver, kidneys, brain, lungs
and testes of every rat, and in most cases the
spleen, pancreas and bladder, were taken for
histological examination. Tissues were fixed in
neutral formalin, and the histological pre-
parations stained with haematoxylin and
eosin.
Chemicalts. Dimethylnitrosamirle (East-
man Kodak, Rochester, N.Y., U.S.A.) was
redistilled before use. Benzo(a)pyrene from
the same source wAas used without further
purification. [14C]Dimethyl-nitrosamine (54
mCi/mmol) was synthesized from [14C]-
dimethylamine (Radiochemicals Centre,
Amersham, U.K.) by the method of Dutton
& Heath (1956) and diluted with DMN as
required.
RESUTLTS
In the (FN rats the LD50, which had
been 35-7 mg/kg body wt (log standard
deviation 0o0685, i.e. between 30 4 and
41'8 mg/kg) in rats fed Purina Chow, was
increased to 60-7 mg/kg body wt (log s.d.
0-0290, i.e. between 56-7 and 65 mg/kg)
by 7 days' pre-treatment with a protein-
free diet. The protein-deficient diet also
protected Osborne Mendel rats, increasing
the LD50 from 316 mg/kg (29.4-34) on
the normal diet, to 46 mg/kg (41.3-51'8),
but did not protect Buffalo rats, where the
LD50 which was 51-6 mg/kg (47.3-55.9)
on the normal diet, actually decreased to
45-2 mg/kg (43.2-47'3) when the rats were
pretreated with the protein-free diet.
A single dose of 40 mg DMN/kg body
wtproduced 0 7 mmol N-7-methylguanine/
mol guanine in the DNA of the pooled
kidneys of 5 CFN rats on a normal diet;
1*2 mnmol in the kidneys of 5 rats on a
protein-free diet; and 1-2 mmol in the
kidneys of 5 rats pre-treated with benzo-
(a)pyrene while on a protein-free diet. In
this experiment the standard deviation of
these numbers was not measured, but in
our experience the variation from rat to
rat was small. In another experiment
the alkylation of liver DNA in 22 separate
rats given DMN had an s.d. of 12%. The
variation in the alkylation of kidney DNA
has not been studied so thoroughly but
appears to be similar.
Liver slices in vitro were able to meta-
bolize DMN to CO2 at the following rates
(nmol C02 produced/g tissue/h): liver
slices from CFN rats on a normal diet,
361 + 29; liver slices from CFN rats after
TABLE I. The mortality among rats treated uwith dimethylnitrosamine (D)MN)
Treatmernt
1)AIN
(mg/kg) t)iet
40 PurIma
Purina
60 Protein-free-
50 Protein-free
40 Proteiin-free
3() Protein-free
20 IProtein-firee
Protein-free
Protein-free +BP*
40 Proteiin-free + BP*
No. rats
treated(
60
25
55
45
55
40
40
25
25
99
No. (lying
in first
24 weeks
16 (27)
0
20 (36)
7 (16)
13 (24)
1 (2:5)
0
1 (4)
55 (55)
No. (lying
25-104
weeks
(O)
32 (53)
10 (40)
34 (62)
37 (82)
42 (76)
32 (80)
20 (50)
6 (24)
11(44)
42 (42)
Survivors
at 104
weeks
(O)
12 (20)
15 (60)
1 (2)
1 (2)
0
7 (17.5)
20 (50)
19 (76)
13 (52)
2 (2)
1
3
4
5
6
7
9
10)
* 20 mg benzo(a)pyrene/kg body wt.
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Fia. 1(a). Fig. I on wlhich is superimpose(d thle
appearance of kidiney tumours in rats given
40 mg DMN/kg after pretreatment, with 20
mg benzo(a)pyrene/kg. (Both treatments
while the rats were temporarily oIn a protein-
free diet.)
7 days on protein-free diet, 90 + 11; liver
slices from CFN rats after 7 days on pro-
tein-free diet and with benzo(a)pyrene
treatment at 4 days, 283 + 28. Kidney
slices from CFN rats were able to metabo-
lize DMN to CO2 at the following rates
*. .: .--- -, . *t .o"r 4aE.,,.,;;
FIG. 1(b).-Fig.1,1 [onjwhieh is superimposedl
the appearance of kidney tumours in rats
given 40 mg D)AN/kg while on a normal
diet.
(same units as for liver): kidney slices
from rats on a normal diet, 29'7 + 1*3;
kidney slices from rats after 7 days on a
protein-free diet, 16-5 + 1G0; kidney slices
from rats after 7 days on a protein-free
diet but with benzo(a)pyrene treatment
at4days, 34-4+30.
The effect of dose on the incidence of
kidney tumours was studied in CFN rats
given either 20, 30, 40, 50 or 60 mg DMN/
kg body wt while on the protein-free diet.
The number of rats in each group is given
in Table I and details of their treatment
in the Materials and Methods section.
Of the 499 rats at the beginning of the
experiment, 390 were alive when the first
kidney tumour was found. Most of the
deaths (107/109) before the first kidney
tumour was found (i.e. in the first 27weeks)
were within the first 2 weeks of the treat-
ment, as a result of the acute toxic effects
of the nitrosamine. 55 (550o) were in the
group pretreated with benzo(a)pyrene,
in comparison with a mortality of 24% in
the group treated with DMN alone (Table
I, GCroup 5). A possible explanation for
this is in the Discussion.
There were very few deaths from natural
causes (infections, etc.) during the course
of the experiment, and the number of
"6--j
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animals lost in this way would be too
small to distort the figures for tumour
incidence materially. For example in the
rats given DMN while on the protein-free
diet (Groups 3-7) most of the tumours
were found between 25 and 75 weeks after
the dose. During this period 126 rats died
with kidney tumours; only 10 from other
causes.
The time of appearance of kidney
tumours in the rats treated with DMN
while on the protein-free diet (Groups
3-7) is shown in Fig. 1. These points
represent the time the rat died and was
subsequently found to have a kidney
tumour, or the time at which the rat was
killed after a kidney tumour had been
detected by palpation. If the tumour
incidence in Fig. 1 at any one time between
50 and 100 weeks is plotted as incidence
vs dose, a sigmoid curve is obtained (e.g.
Fig. 2(a), which shows the results at 60
weeks). These curves can be converted
into straight lines by replotting them as
probit-of-incidence against log dose (for
example Fig. 2(b)), a maximum-likelihood
regression analysis can be carried out, and
fiducial lines calculated (Finney, 1971).
Regression analysis was carried out on the
results in Fig. I at each 10-week interval
between 50 and 100 weeks. The incidence
in probits (Y) can be expressed as a func-
tion, Y =bx+c (where xis the log dose, and
b and c constants), and the standard error
of b and the confidence limits for the posi-
tion of the line (i.e. the standard error of
the probit Y at the weighted median dose
x) calculated. The results were: 50 weeks
b=5-46+0 75, c=-395, Y=4.87+0 10;
60 weeks b=5*65+0-72, c=-3-95 Y=
5-08+0-10; 70 weeks b=6-22+0-81, c=
-4-48, Y=5 30+0 10; 80 weeks b=7-07
+0.84,e=-5 54,Y=5-38+0411;90weeks
b=6d16+0-79,c=-403; Y=5*36+0-11;
I00weeks b=552+0 75; c=-284; Y=
5.53 + 011.
The time of appearance of kidney tu-
mours in the rats treated with DMN and
with benzo(a)pyrene is given in Fig. 1(a),
and in those given DMN on a normal diet
in Fig. 1(b). In each of these figures the
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FIG. 2. The dose response for the induction
of kidney tumours 60 weeks after a single
dose of DMN given while the rats were tem-
porarily on a protein-free diet. (A) The
results are plotted as incidence vs dose (B)
they are plotted as probit of incidence vs
log dose, showing both the calculated regres-
sion line and the 95% fiducial limits.
results from Fig. 1 are also given to
facilitate comparison.
The total number of tumours of the
kidney, lung and other organs is given in
Table II. Of the 85 rats not receiving
DMN, only one had a tumour inthekidney,
and this appeared to be a lipoma. The
kidney tumours in the DMN-treated rats
were either mesenchymal or epithelial.
Several rats had tumours of both kinds
in one kidney. It is difficult to estimate
the exact proportion of tumours which
were epithelial or mesenchymal, since the
rapidly growing mesenchymal tumours
tended to dominate the histology whenever
they were present, but there seemed to be
twice as many epithelial as mesenchymal
tumours (Table III). Seventy-two of the
rats given DMN had lung tumours, either
adduomas or adenocarcinomas. No lung
tumours were found in the untreated rats.
It is reasonable to ascribe the kidney
and lung tumours to the nitrosamine
treatment, though some other types of
tumours were found in both treated and
untreated animals. The majority of these
were fibrosarcomas at several sites, mostly
just below the skin. Some apparently
neoplastic lesions were also found in the
livers; most appeared to be hepatomas,
with a few angiomas and cholangiomas.
Although the incidence of these lesions
was higher in the nitrosamine-treated
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TABLE II.-Tumours in rats treated with DMN
Treatment
DMN
Group (mg/kg) Diet
1 40 Purina
2 Purina
3 60 Protein-free
4 50 Protein-free
5
6
7
8
9
40
30
20
Protein-free
Protein-free
Protein-free
Protein-free
Protein-free + BP*
10 40 Protein-free +BP*
No. with
kidney
No. tumours
ratst (%)
44 22 (50)
25 1 (4)
No. with
lung
tumours
(%)
14 (32)
Other tumours
Liver (7); skin (1); fibrosarcoma
possibly of stomach (1)
Brain (1); pancreas (1);
chondrosarcoma (1); fibrosarcoma
(3)
35 34 (97) 7 (28) Fibrosaremoa (1); liver (1)
38 36 (95) 7 (18) Fibrosarcoma (1); liver (3);
pancreas (1)
42 38 (90) 6 (14) Liver (2); pituitary (1)
39 30 (77) 12 (31) Liver (4)
40 13 (32) 8 (20) Liver (3)
25 0 0 Subcutaneous squamous
carcinoma (1); liver (3)
24 0 0 Liposarcoma (1); fibrosarcoma (3);
pituitary (1); bladder (1)
44 35 (75) 16 (36) Liver (1); fibrosarcoma (3);
bladder (1); testis (1)
* 20 mg benzo(a)pyrene/kg body wt.
t No. rats surviving 25 weeks or more after the dose.
TABLE III.-Histological type of kidney tumour induced by a single dose of DMN
Group
1
3
4
5
6
7
10
Treatment
DMN
(mg/kg) Diet
40 Purina
60 Protein-free
50 Protein-free
40 Protein-free
30 Protein-free
20 Protein-free
40 Protein-free +BP*
No.
rats
with
kidney
tumours
21
34
36
38
30
13
31
No. with
both
mesenchymal
only only and
epithelial mesenchymal epithelial
tumours tumours tumours (0) (%) (%)
18 (86) 3 (14) 0
11 (32) 6 (18) 17 (50)
21 (58) 5 (14) 10 (28)
19 (50) 8 (21) 11 (29)
23 (77) 3 (10) 4 (13)
9 (69) 4 (31) 0
24 (77) 2 (6) 5 (16)
Abbreviations: DMN, dimethylnitrosamine; BP, benzo(a)pyrene.
* 20 mg benzo(a)pyrene/kg.
animals, it is not certain that they were
caused by the nitrosamine treatment: the
incidence of the lesions was not dose-
related, and it is generally accepted that
a single dose of DMN does notinduce liver
tumours (Craddock, 1976).
DISCUSSION
Before the strain of rats for the main
experiments was chosen the effect of the
protein-free diet on the toxicity of DMN
was measured in 3 strains. It was found
that 7 days on the diet reduced the
susceptibility ofCFN and Osborne Mendel
rats to the toxic effects of DMN, but did
not protect the Buffalo rat. Because of
this CFN rats were chosen for all the
subsequent experiments.
The Buffalo is not the only strain in
which the protein-free diet has no effect
on the toxicity of the nitrosamine (Wayn-
forth et al., 1977). The most striking effect
of DMN-poisoning is liver damage, prob-
ably induced by the reactive metabolites
of the nitrosamine. The protein-free diet
decreases the ability of the rat to metabo-
lize DMN. The liver is affected to a greater
extent than other organs, and it is believed
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that this may be the basis for the protec-
tion (Swann & McLean, 1.971). However,
Waynforth ct al. (1977) found that the
protein-free diet decreased the rate of
metabolism in the unprotected as well as
the protected strains. It is not known,
therefore, why there was a different effect,
on toxicity in different strains. The ex-
planation may be that liver damage is not,
the only determinant of death from DMN
poisoning. Effusion into the pleural cavity
and bleeding into the gut are often seen
at necropsy of the poisoned animals
(Barnes & Magee, 1954). A counterpart to
the decrease in the capability of the liver
to metabolize DMN is an increase in the
amount metabolized in other organs
(Swann & McLean, 1.971) which increases
the damage in these organs. It is possible
that in some strains of rat any protective
effect of diet is counterbalanced by an
increase in the contribution of patho-
logical changes in the Itings and other
oro,ans to the death of the animals.
The time of appearance of kidney
tumours in rats given a single dose of
IDMN is given in Fig. 1. In most cases this
was the time that the tumours were of
siifficient size to be detected by palpation,
or to kill the animal. The first tumour was
found 28 weeks after administration of
the carcinogen. It is particularly interest-
ing that some tumours, mostly small
adenomas, were not found until the sur-
viving rats were killed 104 weeks after the
carcinogen had been administered, and
microscopic examination of the kidneys
was carried out. It is difficult to assess
the significance of these lesions, but the
steady increase in the number ofclinically
significant tumours in the groupsgiven the
lower doses (Fig. 1) throughout the period
from 30 to 104 weeks, suggests that, given
sufficient time, many would have pro-
gressed to cancer. This means that one
cannot speak of an absolute incidence of
tumours, onlv ofthe observed incidence at
a given time.
The first tumour was found at 32 weeks
in the rats given 60 mg DMN/kg and at
28. 391 43, and 35 weeks in those given
50. 40. 30, and 20 mg/kg. The lack of a
relationship between dose and the time
of appearance of the first tumour is in
strong contrast to the effect of a single
dose of benzo(rst)pentaphene on the
hamster cheek pouch (Wodinsky et al.,
1965) where the first, tumour appeared
much sooner after a large dose than after
a small one. Although the time to appear-
ance ofthe first tumour was not influenced
by the dose, the average time between the
dose and appearance of each tumour was
much greater in the rats given the lower
doses than in those given the higher doses
(Fig. 1). A relationship between dose and
the time of appearance of tumours has
also been found when brain tumours were
induced in the offspring of rats given a
single dose of ethylnitrosourea (Druckrey
et al., 1970; Swenberg et al., 1972) and in
manyexperiments where carcinogens were
given continuously (Druckrey, 1967).
There was no significant difference be-
tween the time of appearance of the
mesenchymal and epithelial tumours.
It is not known why the first tumour
takes so long to appear, but it isprobably
notsimply the time needed for the tumour
to grow to a sufficient size to be detected.
Microscopic study (liard & Butler, 1971)
has shown that altered cells, which seem to
be precursors of the tumour, can be seen
in the kidney only a few days after the
dose. Yet tumours are notfound, even with
the microscope, until 16 weeks or more
have passed. Similarly, cells taken into
tissue culture from the kidneys of these
rats, 24 h after they have been given the
nitirosamine have altered growth charac-
teristics, but do not transform into fully
malignant cells until after several passages
(Hard & Borland, 1977; Hard, 1978).
Other experiments in tissue culture have
also shown that time is essential for the
full development of malignancy (Laerum
& Raiewsky, 1975; Barrett & Ts'o, 1978;
Roscoe & Claisse, 1978) and are in general
accord with conclusions drawn from
pathology(Foulds, 1969)andmathematical
analysis of the relationship between age
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1971; Peto, 1977) that transformation of
tissue from the normal state to cancer is a
multistage process. The increase in the
average time for the development of
tumours (Fig. 1) as the dose is lowered
suggests the interesting possibility that
the initiation of cancer is not just a switch
from normality to the first premalignant
stage, but a process which propels the cell
towards the malignant state, and that the
time needed to achieve full malignancy
depends upon the intensity of that initial
propulsion, i.e. the nature and dose of
carcinogen.
Previous studies (Swann & McLean,
1971) had shown that pre-treatment with
the protein-free diet altered the pharmaco-
kinetics of the nitrosamine so that a
greater proportion of any dose was acti-
vated to the proximal carcinogen in the
kidney. When designing these experi-
ments we hoped to discover whether the
increase in tumour incidence was entirely
the result of the change in the pharmaco-
kinetics or whether the diet also produced
a change in the inherent susceptibility of
the kidney. To decide this it was necessary
to find the difference in incidence of
tumours when DMN is given to rats on a
protein-free diet, and on a normal diet;
and to compare this with the difference
predicted from knowledge of the pharma-
cokinetics. If there was no difference
between the observed and predicted
differences, there must be no change in
the inherent susceptibility ofthe kidney to
the carcinogen.
The influence ofchanges in diet, or other
treatments, on the metabolism of DMN in
various organs can be estimated by
measuring the metabolism by tissue slices
in vitro, or the alkylation of DNA of
different organs produced by a dose of
DMN in vivo (Swann & McLean, 1971).
The protein-deficient diet increases the
amount of nitrosamine metabolized in the
kidney because metabolism is inhibited
more in the liver than in the kidney
(Swann & McLean, 1971). In these CFN
rats the metabolism of DMN by liver
slices was reduced to 26% of normal by
the protein-free diet, whilst the metabo-
lism by kidney slices was reduced to 56%
of normal. The rat excretes only a small
amount of DMN, so the selective inhibi-
tion of metabolism in the liver increases
the proportion of the dose metabolized in
the kidney and increases the alkylation of
kidney DNA. The amount of alkylation
of kidney DNA of rats on the protein-free
diet was 1*7 times greater than in the
kidneys of rats on a normal diet. If the
tumour incidence was related to the
amount of alkylation one would expect
23 mg DMN/kg in rats on a protein-free
diet to produce the same incidence of
tumours as 40 mg/kg on a normal diet.
The incidence of tumours at various times
in rats given 40 mg DMN/kg on a normal
diet (Fig. 1(b)) can be expressed as probits
and substituted into the equations des-
cribing the dose response in the protein-
deprived rats (Results Section). It is then
estimated that rats on a protein-free diet
require only 24-4 mg DMN/kg to produce
the same incidence. (The individual esti-
mates were 23 4, 25-6, 23-8, 25.0, and
24-0 mg/kgwhen the comparison was made
at 50, 60, 70, 80, 90, and 100 weeks.)
Since the relative effectiveness of the
carcinogen predicted from the amount of
alkylation of kidney DNA produced by
DMN in rats on the 2 dietary regimes
is so similar to the relative effectiveness
observed, it seems that the protein-free
diet produces little change in the inherent
susceptibility of the kidney to this car-
cinogen.
Benzo(a)pyrene pre-treatment partially
reverses the effect of the protein-free diet
on the rate of metabolism of DMN by
liver slices, increasing it from 26% to
78 o ofnormal. One might expecttherefore
that pre-treatment with benzo(a)pyrene
would increase the toxicity of the nitro-
samine. Although a formal LD50 was not
carried out, this prediction accords with
the observation that whereas 24% of the
rats on the protein-free diet were killed
by 40 mg DMN/kg, 550o were killed when
the rats were pre-treated with benzo(a)-
pyrene (Table I).
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The metabolic studies suggested that
pre-treatment with benzo(a)pyrene should
have less effect on the incidence ofkidney
tumours than it had on toxicity. Treat-
ment with benzo(a)pyrene restores the
activity of the liver slices of the protein-
deprived rat to 78% of normal, but in-
creases the activity of kidney slices to
115% ofnormal. Thus although the overall
rate of metabolism had been largely
restored, the balance is towards metabo-
lism by the kidney. The alkylation of
kidney DNA by 40 mg DMN/kg was the
same in the benzo(a)pyrene-treated, pro-
tein-deprived rats, as in those on the pro-
tein-free diet alone (0.12 Hmol N-7-methyl-
guanine/mol guanine). Thus if tumour
incidence were related to the amount of
alkylation one would not expect benzo(a)-
pyrene treatment to affect the kidney-
tumour incidence produced by DMN in
the protein-deprived rat. The results
(Fig. 1(a)) are consistent with that predic-
tion. The incidence of tumours at various
times in the rats given 40 mg DMN after
treatment with benzo(a)pyrene can be
converted to probits and substituted in the
equations given in the results. It is then
found that the apparent median tumori-
genic effect is that expected from 37-1 mg
DMN in the untreated rat (the individual
values are 35 7, 39.4, 39.7, 39.9, 36-8 and
34 0 mg/kg at 50, 60, 70, 80, 90 and 100
weeks).
These results are preliminary, and
further work is needed on the relationship
between the metabolism of DMN, the
alkylation of nucleic acids, and the
catcinogenic activity of the compound.
Theseresultssuggest,however, thatwhen a.
given treatment changes the incidence of
tumours, it should be possible to assess
how much that change is due to a change
in the metabolism of the introsamine and
how much it is due to a change in the
inherent susceptibility of the tissue.
We are most grateful to Laurence Freedman for
his help and advice with the mathematics, and to
Professor H. Druckrey for his interest and encour-
agement. This project has been most generously
supported by the Cancer Research Campaign.
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